Skip to main content
logo
iNtRON Biotechnology, Inc. (KOSDAQ:048530)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,855.00
+55.00 (1.45%)
Jun 24, 2025, 3:30 PM KST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Immuno-oncology Drugs - Product
6.16B
Log In
Log In
Log In
Log In
Upgrade
Immuno-oncology Drugs - Product Growth
-22.80%
Log In
Log In
Log In
Log In
Upgrade
Technology Transfer
111.65M
Log In
Log In
Log In
Log In
Upgrade
Technology Transfer Growth
-91.46%
Log In
Log In
Log In
Log In
Upgrade
Immuno-oncology Drugs - Service
76.56M
Log In
Log In
Log In
Log In
Upgrade
Immuno-oncology Drugs - Service Growth
-64.89%
Log In
Log In
Log In
Log In
Upgrade
Immuno-oncology Drugs - Merchandise
72.04M
Log In
Log In
Log In
Log In
Upgrade
Immuno-oncology Drugs - Merchandise Growth
-13.50%
Log In
Log In
Log In
Log In
Upgrade
Other
187.00K
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-78.75%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
South Korea
6.42B
Log In
Log In
Log In
Log In
Upgrade
South Korea Growth
-33.05%
Log In
Log In
Log In
Log In
Upgrade